Funding for this research was provided by:
Stiftelsen för Kunskaps- och Kompetensutveckling (202100-4920)
Received: 25 May 2022
Accepted: 7 September 2022
First Online: 20 September 2022
: All strains used in this work were preserved and no humans or patients were involved during the course of this study for the isolation of the bacterial samples.
: Not applicable.
: Magnus M. Fazli is Head of Science and Research at SoftOx Solutions, AS, Copenhagen, Denmark. Olivia Aherne receives funding from SoftOx Solutions, AS, Copenhagen. The rest of the authors have no competing interests.